Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.41M Hold
4,000
0.62% 35
2025
Q4
$1.3M Hold
4,000
0.56% 37
2025
Q3
$1.13M Hold
4,000
0.51% 42
2025
Q2
$1.12M Hold
4,000
0.54% 38
2025
Q1
$1.25M Hold
4,000
0.63% 36
2024
Q4
$1.04M Hold
4,000
0.42% 41
2024
Q3
$1.28M Hold
4,000
0.63% 39
2024
Q2
$1.25M Hold
4,000
0.65% 39
2024
Q1
$1.11M Hold
4,000
0.61% 38
2023
Q4
$1.2M Buy
4,000
+1,000
+33% +$272K 0.68% 37
2023
Q3
$799K Hold
3,000
0.55% 37
2023
Q2
$666K Hold
3,000
0.44% 42
2023
Q1
$739K Hold
3,000
0.5% 39
2022
Q4
$788K Hold
3,000
0.56% 37
2022
Q3
$676K Buy
+3,000
New +$727K 0.55% 37
2022
Q1
$725K Hold
3,000
0.48% 45
2021
Q4
$675K Hold
3,000
0.43% 47
2021
Q3
$642K Hold
3,000
0.44% 46
2021
Q2
$731K Buy
+3,000
New +$738K 0.56% 44

Other funds holding AMGN

Boit C.F. David's AMGN Position: Q1 2026 in Review

Boit C.F. David held its Amgen (AMGN) position steady in Q1 2026 at 4,000 shares worth $1.41M. The position accounts for 0.62% of the portfolio, ranked #35.

Boit C.F. David first reported a position in AMGN in Q2 2021 and has held it in 19 quarters since. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Boit C.F. David held 4,000 shares of Amgen worth $1.41M as of Q1 2026.
  • Boit C.F. David left its Amgen share count unchanged in Q1 2026.
  • Amgen made up 0.62% of Boit C.F. David's portfolio in Q1 2026, its #35 holding.
  • Boit C.F. David first reported a position in Amgen in Q2 2021 and has held it in 19 quarters since.
  • 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Boit C.F. David's 13F filing for Q1 2026, filed 9 Apr 2026.